Diametric Capital’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$323K Buy
+13,214
New +$368K 0.03% 462

Other funds holding BEAM

Diametric Capital's BEAM Position: Q3 2026 in Review

Diametric Capital opened a new position in Beam Therapeutics (BEAM) in Q3 2026: 13,214 shares worth $323K. The stake represents 0.03% of the portfolio and ranks #462 among its holdings.

264 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

  • Diametric Capital held 13,214 shares of Beam Therapeutics worth $323K as of Q3 2026.
  • Beam Therapeutics was a new Diametric Capital position in Q3 2026.
  • Beam Therapeutics made up 0.03% of Diametric Capital's portfolio in Q3 2026, its #462 holding.
  • 264 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on Diametric Capital's 13F filing for Q3 2026, filed 16 Nov 2026.